Broken String Biosciences launched BaseMap ABE, a genome-wide off-target characterization platform for adenine base editing therapeutics. The company said its INDUCE-seq-based approach generates biologically relevant data from directly assayed cells, enabling reproducible specificity profiling that can support guide optimization and preclinical program decisions via standardized datasets.